← Browse by Condition
Medical Condition

richter syndrome

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for richter syndrome sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2
2
Top Sponsors
GELLC (Grupo Español de Leucemia Linfocítica Crónica) 1 trial
University of Birmingham 1 trial
NCT06926205 Phase 2
Recruiting

CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Group of CLL

Enrollment
34 pts
Location
Spain
Sponsor
GELLC (Grupo Español de Leucem...
View Trial →
NCT03899337 Phase 2
Recruiting

A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome

Enrollment
105 pts
Location
United Kingdom
Sponsor
University of Birmingham
View Trial →